BRPI0916732A2 - vacina contra hpv - Google Patents

vacina contra hpv

Info

Publication number: BRPI0916732A2
Authority: BR; Brazil
Prior art keywords: hpv vaccine; hpv; vaccine
Prior art date: 2008-07-31

Application number

BRPI0916732A

Other languages

English (en)

Inventor

Descamps Dominique

Stephenne Jean

Anne Cecile Wettendorff Martine

Lecrenier Nicolas

Giannini Sandra

Original Assignee

Glaxosmithkline Biologicals Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-31

Filing date

2009-07-29

Publication date

2017-01-31

2009-07-29 Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa

2017-01-31 Publication of BRPI0916732A2 publication Critical patent/BRPI0916732A2/pt

2021-06-29 Publication of BRPI0916732B1 publication Critical patent/BRPI0916732B1/pt

Links

229960005486 vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

BRPI0916732-3A 2008-07-31 2009-07-29 Vacina para a prevenção de doença ou infecção relacionada ao papilomavirus humano (hpv) compreendendo partículas semelhantes ao vírus hpv 16 e hpv 18 BRPI0916732B1 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US8510108P	2008-07-31	2008-07-31
US61/085,101		2008-07-31
US17656109P	2009-05-08	2009-05-08
US61/176,561		2009-05-08
PCT/EP2009/059820 WO2010012780A1 (en)	2008-07-31	2009-07-29	Vaccine against hpv

Publications (2)

Publication Number	Publication Date
BRPI0916732A2 true BRPI0916732A2 (pt)	2017-01-31
BRPI0916732B1 BRPI0916732B1 (pt)	2021-06-29

Family

ID=41139260

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0916732-3A BRPI0916732B1 (pt)	2008-07-31	2009-07-29	Vacina para a prevenção de doença ou infecção relacionada ao papilomavirus humano (hpv) compreendendo partículas semelhantes ao vírus hpv 16 e hpv 18

Country Status (26)

Country	Link
US (1)	US20110189229A1 (pt)
EP (1)	EP2318042B1 (pt)
JP (1)	JP6022159B2 (pt)
KR (1)	KR20110053340A (pt)
CN (1)	CN102159239A (pt)
AU (1)	AU2009275909A1 (pt)
BR (1)	BRPI0916732B1 (pt)
CA (1)	CA2732436C (pt)
CO (1)	CO6341567A2 (pt)
DK (1)	DK2318042T3 (pt)
DO (1)	DOP2011000031A (pt)
EA (1)	EA201170264A1 (pt)
ES (1)	ES2519490T3 (pt)
HR (1)	HRP20141063T1 (pt)
IL (1)	IL210977A0 (pt)
MA (1)	MA32554B1 (pt)
MX (1)	MX2011001218A (pt)
NZ (1)	NZ590919A (pt)
PE (1)	PE20110327A1 (pt)
PL (1)	PL2318042T3 (pt)
PT (1)	PT2318042E (pt)
RS (1)	RS53607B1 (pt)
SI (1)	SI2318042T1 (pt)
SM (1)	SMT201400170B (pt)
WO (1)	WO2010012780A1 (pt)
ZA (1)	ZA201100889B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2011013744A (es)	2009-06-25	2012-09-28	Glaxosmithkline Biolog Sa	Construcciones novedosas de proteinas del virus de papiloma humano (hpv) y su uso en la prevencion de la enfermedad por el hpv.
CN102178944A (zh) *	2010-09-17	2011-09-14	大连雅立峰生物制药有限公司	人乳头瘤病毒16和18型l1蛋白在昆虫细胞中的表达及应用
CN102229660B (zh)	2011-05-25	2015-04-22	厦门大学	截短的人乳头瘤病毒33型l1蛋白
KR101559622B1 (ko)	2012-07-30	2015-10-13	중앙대학교 산학협력단	인유두종바이러스 바이러스 유사입자의 고효율 정제방법
CN107002085A (zh) *	2014-09-11	2017-08-01	卡迪拉保健有限公司	具有优异免疫学特性的优异的人乳头瘤病毒抗原和含有其的疫苗
US10063211B2 (en)	2016-02-03	2018-08-28	Qualcomm Incorporated	Compact bypass and decoupling structure for millimeter-wave circuits
RU2628693C1 (ru) *	2016-11-10	2017-08-21	федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "ФНИЦЭМ им. Н.Ф. Гамалеи" Минздрава России)	РЕКОМБИНАНТНЫЙ ГЕН L1HPV16, РЕКОМБИНАНТНАЯ ПЛАЗМИДА pQE-L1/16, БЕЛОК L1HPV16 И ИХ ПРИМЕНЕНИЕ
US20210302427A1 (en) *	2020-03-31	2021-09-30	Shuhari Group, LLC	Secure Immunity Information Transmission System And Network
WO2025147639A1 (en) *	2024-01-04	2025-07-10	Cyanvac Llc	Improved formulation providing increased stability for vaccines composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9921146D0 (en) *	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
AU2005222776A1 (en) *	2003-12-31	2005-09-29	Genimmune N.V.	Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
MXPA06014515A (es) *	2004-06-16	2007-03-23	Glaxosmithkline Biolog Sa	Vacuna contra vph16 y vph18 y al menos otro tipo de vph seleccionado de vph 31, 45 o 52.
US7758866B2 (en) *	2004-06-16	2010-07-20	Glaxosmithkline Biologicals, S.A.	Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
KR20080005585A (ko) *	2005-04-26	2008-01-14	글락소스미스클라인 바이오로지칼즈 에스.에이.	백신

2009
- 2009-07-29 SI SI200931047T patent/SI2318042T1/sl unknown
- 2009-07-29 ES ES09781248.1T patent/ES2519490T3/es active Active
- 2009-07-29 AU AU2009275909A patent/AU2009275909A1/en not_active Abandoned
- 2009-07-29 NZ NZ590919A patent/NZ590919A/xx not_active IP Right Cessation
- 2009-07-29 PE PE2011000104A patent/PE20110327A1/es not_active Application Discontinuation
- 2009-07-29 DK DK09781248.1T patent/DK2318042T3/da active
- 2009-07-29 PT PT97812481T patent/PT2318042E/pt unknown
- 2009-07-29 BR BRPI0916732-3A patent/BRPI0916732B1/pt active IP Right Grant
- 2009-07-29 RS RS20140613A patent/RS53607B1/sr unknown
- 2009-07-29 PL PL09781248T patent/PL2318042T3/pl unknown
- 2009-07-29 EP EP09781248.1A patent/EP2318042B1/en active Active
- 2009-07-29 EA EA201170264A patent/EA201170264A1/ru unknown
- 2009-07-29 WO PCT/EP2009/059820 patent/WO2010012780A1/en not_active Ceased
- 2009-07-29 CA CA2732436A patent/CA2732436C/en active Active
- 2009-07-29 US US13/056,452 patent/US20110189229A1/en not_active Abandoned
- 2009-07-29 JP JP2011520506A patent/JP6022159B2/ja active Active
- 2009-07-29 HR HRP20141063AT patent/HRP20141063T1/hr unknown
- 2009-07-29 CN CN200980135875XA patent/CN102159239A/zh active Pending
- 2009-07-29 MX MX2011001218A patent/MX2011001218A/es not_active Application Discontinuation
- 2009-07-29 KR KR1020117004436A patent/KR20110053340A/ko not_active Withdrawn
2011
- 2011-01-28 DO DO2011000031A patent/DOP2011000031A/es unknown
- 2011-01-31 IL IL210977A patent/IL210977A0/en unknown
- 2011-02-03 ZA ZA2011/00889A patent/ZA201100889B/en unknown
- 2011-02-11 MA MA33605A patent/MA32554B1/fr unknown
- 2011-02-23 CO CO11022213A patent/CO6341567A2/es not_active Application Discontinuation
2014
- 2014-11-10 SM SM201400170T patent/SMT201400170B/xx unknown

Also Published As

Publication number	Publication date
US20110189229A1 (en)	2011-08-04
CO6341567A2 (es)	2011-11-21
HRP20141063T1 (hr)	2015-01-02
EP2318042B1 (en)	2014-08-20
PE20110327A1 (es)	2011-06-29
CN102159239A (zh)	2011-08-17
CA2732436C (en)	2018-01-16
RS53607B1 (sr)	2015-04-30
EA201170264A1 (ru)	2011-08-30
BRPI0916732B1 (pt)	2021-06-29
PL2318042T3 (pl)	2015-02-27
DK2318042T3 (da)	2014-11-10
JP2011529475A (ja)	2011-12-08
SMT201400170B (it)	2015-01-15
ES2519490T3 (es)	2014-11-07
SI2318042T1 (sl)	2014-12-31
ZA201100889B (en)	2012-04-25
WO2010012780A1 (en)	2010-02-04
MA32554B1 (fr)	2011-08-01
NZ590919A (en)	2012-10-26
CA2732436A1 (en)	2010-02-04
JP6022159B2 (ja)	2016-11-09
IL210977A0 (en)	2011-04-28
MX2011001218A (es)	2011-03-15
AU2009275909A1 (en)	2010-02-04
KR20110053340A (ko)	2011-05-20
PT2318042E (pt)	2014-11-05
DOP2011000031A (es)	2011-02-28
EP2318042A1 (en)	2011-05-11

Legal Events

Date	Code	Title	Description
2017-02-21	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-03-19	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2020-02-18	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2020-09-01	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2020-12-15	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2021-05-04	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-06-29	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/07/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, , QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

Publication	Publication Date	Title
DK2049559T3 (da)	2013-03-25	Forbedrede HPV vacciner
GB0810305D0 (en)	2008-07-09	Influenza vaccination
IL211233A0 (en)	2011-04-28	Vaccine
DK2114993T3 (da)	2012-10-22	Vaccine
BRPI0916732A2 (pt)	2017-01-31	vacina contra hpv
IL208651A0 (en)	2010-12-30	Vaccine
GB0822001D0 (en)	2009-01-07	Vaccine
GB0810710D0 (en)	2008-07-16	Vaccine
IL208652A0 (en)	2010-12-30	Vaccine
EP2442827A4 (en)	2013-04-17	NANO EMULSION VACCINES
GB0816447D0 (en)	2008-10-15	Vaccine
GB0816284D0 (en)	2008-10-15	Vaccine
BRPI0921578A2 (pt)	2019-09-24	vacinas unitemporais
DK2279652T3 (da)	2012-11-26	Kultivator
BRPI1015272A2 (pt)	2015-08-25	Fermentação
FR2947195B1 (fr)	2011-08-26	Translateur ultravide
BRPI0918719A2 (pt)	2015-12-01	vacina contra nematódeos
DE102009039027A8 (de)	2011-06-01	Abziehvorrichtung
FI9141U1 (fi)	2011-03-15	Apuväline
GB0920319D0 (en)	2010-01-06	HPV vaccine
IT1395452B1 (it)	2012-09-21	Microemulsioni
ITNU20080001U1 (it)	2009-09-13	Tenaglia easy pincer
ES1067420Y (es)	2008-08-16	Ataud desmontable
FI8702U1 (fi)	2010-04-19	Apuväline
HK1150765A (en)	2012-01-13	Vaccine against hpv